Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of mupA EVIGENE assay for determination of high-level mupirocin resistance in Staphylococcus aureus.

Journal of clinical microbiology - 1 Nov 2010

Rasmussen Anne K I, Skov Robert L, Venezia Richard A, Johnson Jennifer K, Stender Henrik

Abstract excerpt

Mupirocin is widely used to decolonize patients carrying Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA). The aim of this study was to determine the presence of high-level mupirocin resistance by a new commercially available mupA genotypic diagnostic product, mupA EVIGENE assay (AdvanDx).

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to DNA, Bacterial
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microbial Sensitivity Tests

Share to Nuclear Proteins

Share to Nucleic Acid Hybridization

Share to Sensitivity and Specificity

Share to Staphylococcus aureus

Source

Open in PubMed Open full text

Identifiers

PMID: 20810775
DOI: 10.1128/JCM.00088-10
PMCID: PMC3020815

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of mupA EVIGENE assay for determination of high-level mupirocin resistance in Staphylococcus aureus.PMID 20810775Read ↗

MOLECULAR CHARACTERIZATION OF VANCOMYCIN, MUPIROCIN AND ANTISEPTIC RESISTANT STAPHYLOCOCCUS AUREUS STRAINS.Semantic proximity Read ↗

Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistanceSemantic proximity Read ↗

Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance.Semantic proximity Read ↗

Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus (MRSA) in France: emergence of a mupirocin-resistant MRSA clone harbouring mupASemantic proximity Read ↗

Mupirocin Resistance in Isolates of Staphylococcus spp. from Nasal Swabs in a Tertiary Hospital in France.Semantic proximity Read ↗

Genotypic and phenotypic characterization of methicillin-resistant Staphylococcus aureus (MRSA) clones with high-level mupirocin resistance.Semantic proximity Read ↗

Genomic and Phenotypic Characterization of Mupirocin-resistant Staphylococcus aureus Clinical IsolatesSemantic proximity Read ↗

Clinical relevance of mupirocin resistance in Staphylococcus aureusSemantic proximity Read ↗

Prevalence of clinical meticillin-resistant Staphylococcus aureus (MRSA) with high-level mupirocin resistance in Shanghai and Wenzhou, China.Semantic proximity Read ↗

Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States.Semantic proximity Read ↗

Accuracy of PCR universal primer for methicillin-resistant Staphylococcus and comparison of different phenotypic screening assays.Semantic proximity Read ↗

Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.